Panacea Biotec launches diabetes drug 'Tenepan'

Drug firm Panacea Biotec has launched diabetes drug 'Tenepan', used for treating Type 2 Diabetes Mellitus, in the country.
Tenapan aims to improve accessibility of diabetes treatment at an affordable cost as part of the company's commitment to the 'Make in India' campaign, Panacea Biotec said in a regulatory filing.
"Panacea Biotec has always endeavored to partner with medical practitioners in assisting to manage their patients better by introducing new innovative and good quality products," Panacea Biotec Joint Managing Director Rajesh Jain said.
With the launch of Tenepan the company intends to reach out to the patients with the latest therapeutic treatment, he added.

According to the data published last year, diabetes has affected 69.1 million people in India and 415 million people worldwide.
Panacea shares were trading nearly 10 per cent up at Rs 127.25 apiece on BSE.